Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor metadata/version update to the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.6.4 now appears on the page, replacing the previous v3.6.3. This denotes a minor update to the page's revision metadata rather than substantive changes to the study details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous v3.6.2, signaling a version update to the page or its documents.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded a new 2024 publication citation about long-term safety of gantenerumab (Marguerite RoAD) to the Publications section. Updated the revision tag from v3.6.0 to v3.6.2.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now includes a recruitment status update and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a Revision: v3.6.0 note; the previous text items 'Intervention / Treatment' and 'Revision: v3.5.5' were removed.SummaryDifference0.2%

- Check75 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This represents a minor update to the page version and does not change any study information.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.